Menopause Hormone Therapy (HRT) in Lakewood, NJ

Bioidentical hormones in Lakewood: what it means

Behind the label "bioidentical hormone replacement therapy" is a plain idea: a hormone whose structure matches the body's own. Two hormones used in menopause care fit it exactly, estradiol and micronized progesterone. FDA-approved versions of both are sold by prescription at retail pharmacies.

"BHRT" often means compounded hormones, a cream, a blend such as Bi-Est or a pellet that a pharmacy mixes for one prescription. They are not FDA-approved, which means the FDA cannot assure their safety or effectiveness. The FDA says it has no evidence that compounded "bioidentical hormones" are safe and effective, or more effective than FDA-approved hormone therapy. The National Academies, reviewing them for the FDA in 2020, called their wide use a public health concern.

For women in Lakewood, a physician licensed in New Jersey can prescribe estradiol (pill, patch, cream or vaginal) and progesterone when they fit your history. There are no pellets. The pharmacy that fills VevaMD prescriptions also compounds, so ask your physician whether yours is an FDA-approved product or compounded. Two options are compounded for certain: testosterone cream for women and Bi-Est are not FDA-approved.

For its size, Lakewood is well supplied with OB-GYNs: the NPI registry lists 18, or 25.8 per 100,000 residents, against 17.8 for the US and above New Jersey's 19.9. That is about 190 women aged 45 to 64 for each OB-GYN in the city, a ratio rather than a count of open appointments.

Widen the circle and the count grows: 93 in the city or within 10 miles, 243 within 25 miles. For the 1,467,196 people who live within 25 miles, that is 16.6 per 100,000. Whether or not you have an OB-GYN, you can ask a physician licensed in New Jersey about menopause hormone therapy online from Lakewood, with no waiting room.

BHRT pellet clinics work differently: they place a hormone pellet under the skin in the office, and compounded pellets are not FDA-approved. The Endocrine Society points to a study that found hormone levels well above the expected range in women using them. ACOG advises FDA-approved hormone therapy over compounded preparations.

Sources: FDA: Menopause · FDA: National Academies study of compounded bioidentical hormones (2020) · Endocrine Society position statement on compounded bioidentical hormones (2019) · ACOG Clinical Consensus No. 6, compounded bioidentical menopausal hormone therapy (2023) · CMS NPPES NPI full file, 2026-10-11